Abstract
Inhibition of the serotonin transporter (5-HTT) is a principal initial target of many antidepressants. However, the contribution of the 5-HTT to their therapeutic efficacy is incompletely understood. We utilized a targeted gene mutation approach to examine the role of the 5-HTT in the behavioral actions of antidepressants. The 5-HTT mutation was bred onto two separate genetic backgrounds, C57BL/6J and 129S6. On a preliminary screen for gross physical, neurological and behavioral functions, all measures were normal with the exception that 5-HTT −/− mice on the C57BL/6J background showed increased body weight and poor rotarod performance, and 5-HTT −/− mice on the 129S6 background showed reduced neuromuscular strength. On the tail suspension test, 5-HTT −/− mice on the 129S6 background showed a baseline antidepressant-like reduction in immobility. In contrast, the same mice showed increased immobility in the forced swim test, possibly due to compromised neuromuscular strength. 5-HTT −/− mice on the C57BL/6J background showed no baseline antidepressant-related phenotype on either test. The behavioral effects of three antidepressants were tested in 5-HTT mutant mice (C57BL/6J background) in the tail suspension test. The anti-immobility effects of the serotonin reuptake inhibitor, fluoxetine (30 mg/kg), were abolished in 5-HTT −/− mice, confirming that the 5-HTT gene is required for the behavioral effects of fluoxetine. In contrast, 5-HTT−/− mice retained sensitivity to the anti-immobility effects of the norepinephrine reuptake inhibitor, desipramine (20 mg/kg), and the mixed serotonin/norepinephrine reuptake inhibitor, imipramine (25 mg/kg). 5-HTT knockout mice provide a valuable tool for delineating the neuropsychopharmacological actions of antidepressants.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Battersby S, Ogilvie AD, Smith CA, Blackwood DH, Muir WJ, Quinn JP, Fink G, Goodwin GM, Harmar AJ . ( 1996 ): Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder . Psychiatr Genet 6 : 177 – 181
Bel N, Artigas F . ( 1996 ): In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies . J Pharmacol Exp Ther 278 : 1064 – 1072
Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP . ( 1998 ): Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (”Ecstasy”) in serotonin transporter-deficient mice . Mol Pharmacol 53 : 649 – 655
Blakely RD, Berson HE, Fremeau RT Jr, Caron MG, Peek MM, Prince HK, Bradley CC . ( 1991 ): Cloning and expression of a functional serotonin transporter from rat brain . Nature 354 : 66 – 70
Blier P, de Montigny C, Chaput Y . ( 1990 ): A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence . J Clin Psychiat 51 : S : 14 – 20
Borsini F, Cesana R, Vidi A, Mennini T . ( 1991 ): Evidence that imipramine activates 5–HT1C receptor function . Eur J Pharmacol 203 : 359 – 363
Borsini F . ( 1995 ): Role of the serotonergic system in the forced swimming test . Neurosci Biobehav R 19 : 377 – 395
Bourin M, Hascoet M, Colombel MC, Redrobe JP, Baker GB . ( 1996 ): Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotoninergic systems . Eur Neuropsychopharm 6 : 231 – 236
Brown GL, Linnoila MI . ( 1990 ): CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence . J Clin Psychiat 51 : 31 – 41
Caston J, Devulder B, Jouen F, Lalonde R, Delhaye-Bouchaud N, Mariani J . ( 1999 ): Role of an enriched environment on the restoration of behavioral deficits in Lurcher mutant mice . Dev Psychobiol 35 : 291 – 303
Cesana R, Ceci A, Ciprandi C, Borsini F . ( 1993 ): Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced swimming test in mice . J Pharm Pharmacol 45 : 473 – 475
Chaput Y, de Montigny C, Blier P . ( 1991 ): Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat . Neuropsychopharmacology 5 : 219 – 229
Charney DS . ( 1998 ): Monoamine dysfunction and the pathophysiology and treatment of depression . J Clin Psychiat 59 : 11 – 14
Clenet F, De Vos A, Bourin M . ( 2001 ): Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice . Eur Neuropsychopharm 11 : 145 – 152
Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, Aitchison KJ, Sodhi M, Li T, Roberts GW, Smith B, Morton J, Murray RM, Smith D, Kirov G . ( 1996a ): The serotonin transporter is a potential susceptibility factor for bipolar affective disorder . Neuroreport 7 : 1675 – 1679
Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Muller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP . ( 1996b ): A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders . Mol Psychiatr 1 : 453 – 460
Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA . ( 2002 ): cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs . J Neurosci 22 : 3262 – 3268
Crawley JN, Paylor R . ( 1997 ): A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice . Horm Behav 31 : 197 – 211
Crawley JN . ( 2000 ): What's Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout mice . New York, Wiley-Liss
Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucki I, Thomas SA . ( 2001 ): Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs . J Pharmacol Exp Ther 298 : 651 – 657
Cryan JF, Lucki I . ( 2000 ): Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors . J Pharmacol Exp Ther 295 : 1120 – 1126
David DJ, Nic Dhonnchadha BA, Jolliet P, Hascoet M, Bourin M . ( 2001 ): Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? Behav Brain Res 119 : 203 – 211
Daws LC, Montanez S, Gould GG, Owens WA, Frazer A, Murphy DL . ( 2001 ): Influence of genetic knockout (KO) of the serotonin transporter (5-HTT) on kinetics of 5-HT clearance and 5–HT1B receptor regulation of 5-HT clearance in vivo . Soc Neurosci Abstr 27 : 814.18
Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR . ( 1990 ): Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan . Arch Gen Psychiat 47 : 411 – 418
Delgado PL, Price LH, Miller HL, Salomon RM, Licinio J, Krystal JH, Heninger GR, Charney DS . ( 1991 ): Rapid serotonin depletion as a provocative challenge test for patients with major depression: relevance to antidepressant action and the neurobiology of depression . Psychopharmacol Bull 27 : 321 – 330
de Montigny C, Chaput Y, Blier P . ( 1991 ): Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers . J Clin Psychiatry 51 : S : 4 – 8
Do-Rego JC, Suaudeau C, Chapouthier G, Costentin J . ( 2002 ): Mouse lines differing in sensitivity to beta-CCM differ in tasks used for testing antidepressants . Pharmacol Biochem Behav 72 : 411 – 416
Duman RS . ( 1998 ): Novel therapeutic approaches beyond the serotonin receptor . Biol Psychiat 44 : 324 – 335
Eckeli AL, Dach F, Rodrigues AL . ( 2000 ): Acute treatments with GMP produce antidepressant-like effects in mice . Neuroreport 11 : 1839 – 1843
Feighner JP, Boyer WF . Selective serotonin re-uptake inhibitors: advances in basic research and clinical practice, 2nd ed . New York, Wiley & Sons
Frazer A . ( 1997 ): Antidepressants . J Clin Psychiat 58 : 9 – 25
Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES, Easton DF, Rubinsztein DC . ( 1998 ): Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders . Am J Med Genet 81 : 58 – 63
Gerlai R, Thibodeaux H, Palmer JT, van Lookeren Campagne M, Van Bruggen N . ( 2000 ): Transient focal cerebral ischemia induces sensorimotor deficits in mice . Behav Brain Res 108 : 63 – 71
Gobbi G, Murphy DL, Lesch K, Blier P . ( 2001 ): Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study . J Pharmacol Exp Ther 296 : 987 – 995
Heninger GR, Delgado PL, Charney DS . ( 1996 ): The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans . Pharmacopsychiatry 29 : 2 – 11
Holmes A, Hollon TR, Liu Z, Sibley DR, Dreiling J, Gleason TC, Crawley JN . ( 2001 ): Dopamine D5 receptor null mutant mice show attenuated behavioral responses to a dopamine agonist . Behav Neurosci 115 : 1129 – 1144
Holmes A, Yang RJ, Crawley JN . ( 2002 ): Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice . J Mol Neurosci 18 : 151 – 165
Jenck F, Moreau JL, Mutel V, Martin JR, Haefely WE . ( 1993 ): Evidence for a role of 5–HT1C receptors in the antiserotonergic properties of some antidepressant drugs . Eur J Pharmacol 231 : 223 – 229
Liu X, Gershenfeld HK . ( 2001 ): Genetic differences in the tail-suspension test and its relationship to imipramine response among 11 inbred strains of mice . Biol Psychiat 49 : 575 – 581
Lucki I, Dalvi A, Mayorga AJ . ( 2001 ): Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice . Psychopharmacology ( Berl ) 155 : 315 – 322
Maes M, Meltzer HY . ( 1995 ): The serotonin hypothesis of depression . In Bloom FE, Kupfer DJ (eds), Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, pp 933 – 944
Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS . ( 1998 ): Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography . Biol Psychiat 44 : 1090 – 1098
Manji HK, Drevets WC, Charney DS . ( 2001 ): The cellular neurobiology of depression . Nat Med 7 : 541 – 547
Mann JJ . ( 1999 ): Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior . Neuropsychopharmacology 21 : S : 99 – 105
Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, Dwork AJ, Arango VA . ( 2000 ): Serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide . Arch Gen Psychiat 57 : 729 – 738
Mathews TA, Fedele DE, Unger EL, Lesch KP, Murphy DL, Andrews AM . ( 2000 ): Effects of serotonin transporter inactivation on extracellular 5-HT levels, in vivo microdialysis recovery and MDMA-induced release of serotonin and dopamine in mouse striatum . Soc Neurosci Abstr 26 : 624.3
Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I . ( 2001 ): Antidepressant-like behavioral effects in 5-hydroxytryptamine(1a) and 5-hydroxytryptamine(1b) receptor mutant mice . J Pharmacol Exp Ther 298 : 1101 – 1107
Mayorga AJ, Lucki I . ( 2001 ): Limitations on the use of the C57BL/6 mouse in the tail suspension test . Psychopharmacology ( Berl ) 155 : 110 – 112
Menza MA, Palermo B, DiPaola R, Sage JI, Ricketts MH . ( 1999 ): Depression and anxiety in Parkinson's disease: possible effect of genetic variation in the serotonin transporter . J Geriatr Psych Neur 12 : 49 – 52
Montkowski A, Poettig M, Mederer A, Holsboer F . ( 1997 ): Behavioural performance in three substrains of mouse strain 129 . Brain Res 762 : 12 – 18
Montgomery SA, den Boer JA . ( eds ) ( 2001 ): SSRIs in depression and anxiety. New York: Wiley
Murphy DL . ( 1990 ): Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems . Neuropsychopharmacology 3 : 457 – 471
Murphy DL, Li Q, Engel S, Wichems C, Andrews A, Lesch KP, Uhl G . ( 2001 ): Genetic perspectives on the serotonin transporter . Brain Res Bull 56 : 487 – 494
Murphy DL, Wichems C, Li Q, Heils A . ( 1999 ): Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission . Trends Pharmacol Sci 20 : 246 – 252
Nemeroff CB, Knight DL, Franks J, Craighead WE, Krishnan KR . ( 1994 ): Further studies on platelet serotonin transporter binding in depression . Am J Psychiat 151 : 1623 – 1625
O'Neill MF, Conway MW . ( 2001 ): Role of 5-HT(1A) and 5-HT(1B) receptors in the mediation of behavior in the forced swim test in mice . Neuropsychopharmacology 24 : 391 – 398
Owens MJ, Nemeroff CB . ( 1998 ): The serotonin transporter and depression . Depress Anxiety 8 : S : 5 – 12
Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I . ( 1999 ): Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test . Psychopharmacology ( Berl ) 147 : 162 – 167
Pälvimäki EP, Roth BL, Majasuo H, Laakso A, Kuoppamaki M, Syvalahti E, Hietala J . ( 1996 ): Interactions of selective serotonin reuptake inhibitors with the serotonin 5–HT2c receptor . Psychopharmacology ( Berl ) 126 : 234 – 240
Perrault G, Morel E, Zivkovic B, Sanger DJ . ( 1992 ): Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice . Pharmacol Biochem Behav 42 : 45 – 47
Pinder RM, Wieringa JH . ( 1993 ): Third-generation antidepressants . Med Res Rev 13 : 259 – 325
Porsolt RD, Le Pichon M, Jalfre M . ( 1977 ): Depression: a new animal model sensitive to antidepressant treatments . Nature 266 : 730 – 732
Porsolt RD . ( 2000 ): Animal models of depression: utility for transgenic research . Rev Neurosci 11 : 53 – 58
Ranganathan R, Sawin ER, Trent C, Horvitz HR . ( 2001 ): Mutations in the Caenorhabditis elegans serotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine . J Neurosci 21 : 5871 – 5884
Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD . ( 1993 ): Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization . Proc Natl Acad Sci USA 90 : 2542 – 2546
Redrobe JP, Bourin M . ( 1997 ): Partial role of 5–HT2 and 5–HT3 receptors in the activity of antidepressants in the mouse forced swimming test . Eur J Pharmacol 325 : 129 – 135
Redrobe JP, MacSweeney CP, Bourin M . ( 1996 ): The role of 5–HT1A and 5–HT1B receptors in antidepressant drug actions in the mouse forced swimming test . Eur J Pharmacol 318 : 213 – 220
Rees M, Norton N, Jones I, McCandless F, Scourfield J, Holmans P, Moorhead S, Feldman E, Sadler S, Cole T, Redman K, Farmer A, McGuffin P, Owen MJ, Craddock N . ( 1997 ): Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT) . Mol Psychiatr 2 : 398 – 402
Tatsumi M, Groshan K, Blakely RD, Richelson E . ( 1997 ): Pharmacological profile of antidepressants and related compounds at human monoamine transporters . Eur J Pharmacol 340 : 249 – 258
Seretti A, Cusin C, Lattuada E, Di Bella D, Catalano M, Smeraldi E . ( 1999 ): Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders . Mol Psychiatr 4 : 280 – 283
Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M . ( 1998 ): Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine . Mol Psychiatr 3 : 508 – 511
Srivastava SK, Nath C . ( 2000 ): The differential effects of calcium channel blockers in the behavioural despair test in mice . Pharmacol Res 42 : 293 – 297
Stahl SM . ( 1998 ): Not so selective serotonin reuptake inhibitors . J Clin Psychiat 59 : 343 – 344
Steru L, Chermat R, Thierry B, Simon P . ( 1985 ): The tail suspension test: a new method for screening antidepressants in mice . Psychopharmacology ( Berl ) 85 : 367 – 370
Trullas R, Jackson B, Skolnick P . ( 1989 ): Genetic differences in a tail suspension test for evaluating antidepressant activity . Psychopharmacology ( Berl ) 99 : 287 – 288
van der Heyden JA, Molewijk E, Olivier B . ( 1987 ): Strain differences in response to drugs in the tail suspension test for antidepressant activity . Psychopharmacology ( Berl ) 92 : 127 – 130
Vaugeois JM, Passera G, Zuccaro F, Costentin J . ( 1997 ): Individual differences in response to imipramine in the mouse tail suspension test . Psychopharmacology ( Berl ) 134 : 387 – 391
Willner P . ( 1985 ): Antidepressants and serotonergic neurotransmission: an integrative review . Psychopharmacology ( Berl ) 85 : 387 – 404
Wong EH, Sonders MS, Amara SG, Tinholt PM, Piercey MF, Hoffmann WP, Hyslop DK, Franklin S, Porsolt RD, Bonsignori A, Carfagna N, McArthur RA . ( 2000 ): Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor . Biol Psychiat 47 : 818 – 829
Zanardi R, Benedetti F, Di Bella D, Catalano M, Smeraldi E . ( 2000 ): Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene . J Clin Psychopharm 201 : 105 – 107
Zanardi R, Serretti A, Rossini D, Franchini L, Cusin C, Lattuada E, Dotoli D, Smeraldi E . ( 2001 ): Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-httlpr in delusional and nondelusional depression . Biol Psychiat 50 : 323 – 330
Acknowledgements
Research was supported by the National Institute of Mental Health Intramural Research Program.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Holmes, A., Yang, R., Murphy, D. et al. Evaluation of Antidepressant-related Behavioral Responses in Mice Lacking the Serotonin Transporter. Neuropsychopharmacol 27, 914–923 (2002). https://doi.org/10.1016/S0893-133X(02)00374-3
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(02)00374-3
Keywords
This article is cited by
-
Behavioral phenotype, intestinal microbiome, and brain neuronal activity of male serotonin transporter knockout mice
Molecular Brain (2023)
-
The serotonin transporter sustains human brown adipose tissue thermogenesis
Nature Metabolism (2023)
-
Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression
Neurotherapeutics (2022)
-
Tianeptine, but not fluoxetine, decreases avoidant behavior in a mouse model of early developmental exposure to fluoxetine
Scientific Reports (2021)
-
Protrudin-deficient mice manifest depression-like behavior with abnormalities in activity, attention, and cued fear-conditioning
Molecular Brain (2020)
